Allogene Therapeutics Other Current Liabilities

Allogene Therapeutics (ALLO) currently reports a other current liabilities of $26M as of June 2026. That compares with $27M in the prior-year period — down 4.0% year over year. Use the charts on this page to explore Allogene Therapeutics's other current liabilities history and peer comparisons.

Allogene Therapeutics's other current liabilities decreased from $27M to $26M — a 4.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Allogene Therapeutics reported $26M in other current liabilities as of June 2026. That compares with $27M in the prior-year period — down 4.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allogene Therapeutics, and consider following ALLO for alerts when major investors trade the stock.

Allogene Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $26M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALLO with unrelated industries.